Canary Medical received FDA breakthrough device designation for its Canturio lumbar cartridge, a smart sensor application for spine surgery. The application provides kinematic data for assessing treatment and risk of degenerative disc disease, instability, and non-fusion in spine surgery patients. This is the fourth Canary Medical product to receive breakthrough device designation from the FDA. CEO Bill Hunter expressed pride in this accomplishment.
Source link
Canary Medical receives FDA breakthrough device designation for smart lumbar cartridge
